Table: Zeria Pharm -2023/24 group results

Zeria Pharmaceutical

09/05/2024 08:00

May 9 (Reuters)- 
          Zeria Pharmaceutical Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Mar 31, 2024    Mar 31, 2023   Mar 31, 2025     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           75.73           68.38          83.00        41.00    
               (+10.7 pct)     (+14.9 pct)    (+9.6 pct)   (+11.8 pct) 
  Operating        9.62            9.01          10.00         5.60    
               (+6.7 pct)      (+41.6 pct)    (+3.9 pct)    (+5.1 pct) 
  Recurring        8.51            7.58          10.00         5.60    
               (+12.3 pct)     (+27.7 pct)    (+17.5 pct)   (+1.9 pct) 
  Net
  Net              7.73            6.20           7.80         4.30    
               (+24.8 pct)     (+56.4 pct)    (+0.9 pct)   (-20.3 pct) 
  EPS          175.39 yen      140.26 yen     176.95 yen    97.55 yen  
  Ann Div       44.00 yen       40.00 yen      46.00 yen               
  -Q2 Div       22.00 yen       18.00 yen      23.00 yen               
  -Q4 Div       22.00 yen       22.00 yen      23.00 yen               
  
  NOTE - Zeria Pharmaceutical Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4559.T